Peptic ulcer bleeding in patients with or without cirrhosis: different diseases but the same prognosis?
- PMID: 22607536
- DOI: 10.1111/j.1365-2036.2012.05140.x
Peptic ulcer bleeding in patients with or without cirrhosis: different diseases but the same prognosis?
Abstract
Background: Physiopathology and prognosis of peptic ulcer bleeding (PUB) have never been described in cirrhotic patients.
Aim: To assess risk factors and outcome of PUB in two groups of patients with PUB with or without cirrhosis.
Methods: We included prospectively all patients with PUB referred to our ICU of Hepatology and Gastroenterology between January 2008 and March 2011. All patients were treated according to international recommendations. Diagnosis of cirrhosis was based on clinical, biological and morphological exams. Aetiologies, characteristics and outcomes of PUB were compared in cirrhotic vs. noncirrhotic patients.
Results: A total of 203 patients with PUB were included prospectively. Twenty-nine patients had cirrhosis (group Cirr+), and 174 patients had no cirrhosis (group Cirr-). Demographic data were similar between the two groups except for age and alcohol consumption. Aetiology of cirrhosis was alcohol in 97% of cirrhotic patients. Characteristics of PUB were not different between the two groups. Ninety-three per cent of patients with cirrhosis had endoscopic portal hypertension. Aetiology of PUB was different between the group Cirr+ and Cirr- (Helicobacter pylori = 10.3% vs. 48.8%, P < 0.0001; NSAID's = 17.2% vs. 54.0%, P < 0.0001; idiopathic PUB = 79.3% vs. 23.8%, P < 0.0001). Outcome was comparable concerning re-bleeding (7.0% vs. 6.9%, P = 0.31), need for arterial embolisation (10.3 vs. 8.6%, P = 0.76), need for salvage surgery (0 vs. 1.7%, P = 0.31) and mortality (3.0% vs. 1.1%, P = 0.87).
Conclusions: Physiopathology of PUB seems to be different in patients with cirrhosis. In cirrhotic patients, PUB occurs almost only in alcoholics. In our series, prognosis was similar to general population. PUB in cirrhosis might be related to portal hypertension and/or alcohol.
© 2012 Blackwell Publishing Ltd.
Comment in
-
Letter: peptic ulcer bleeding in patients with cirrhosis.Aliment Pharmacol Ther. 2012 Sep;36(6):597-8; author reply 598. doi: 10.1111/j.1365-2036.2012.05184.x. Aliment Pharmacol Ther. 2012. PMID: 22913844 No abstract available.
-
Letter: Peptic ulcer bleeding and liver cirrhosis--different diseases and different prognosis, too?Aliment Pharmacol Ther. 2013 Feb;37(3):368-9. doi: 10.1111/apt.12155. Aliment Pharmacol Ther. 2013. PMID: 23281728 No abstract available.
-
Letter: Peptic ulcer bleeding and liver cirrhosis--different diseases and different prognosis, too? Authors' reply.Aliment Pharmacol Ther. 2013 Feb;37(3):369-70. doi: 10.1111/apt.12181. Aliment Pharmacol Ther. 2013. PMID: 23281729 No abstract available.
Similar articles
-
Clinical characteristics of Helicobacter pylori-negative drug-negative peptic ulcer bleeding.World J Gastroenterol. 2015 Jul 28;21(28):8636-43. doi: 10.3748/wjg.v21.i28.8636. World J Gastroenterol. 2015. PMID: 26229405 Free PMC article.
-
Analysis of the risk factors and their combinations in acute gastroduodenal ulcer bleeding: a case-control study.Scand J Gastroenterol. 2007 Dec;42(12):1395-403. doi: 10.1080/00365520701478758. Scand J Gastroenterol. 2007. PMID: 17994466
-
Risk of peptic ulcer bleeding associated with Helicobacter pylori infection, nonsteroidal anti-inflammatory drugs, low-dose aspirin, and antihypertensive drugs: a case-control study.J Gastroenterol Hepatol. 2015 Feb;30(2):292-8. doi: 10.1111/jgh.12805. J Gastroenterol Hepatol. 2015. PMID: 25339607
-
Effect of Helicobacter pylori infection and NSAIDs on the risk of peptic ulcer bleeding.J Med Assoc Thai. 2004 Sep;87 Suppl 2:S295-9. J Med Assoc Thai. 2004. PMID: 16083206 Review.
-
Meta-analysis: Helicobacter pylori eradication therapy vs. antisecretory non-eradication therapy for the prevention of recurrent bleeding from peptic ulcer.Aliment Pharmacol Ther. 2004 Mar 15;19(6):617-29. doi: 10.1111/j.1365-2036.2004.01898.x. Aliment Pharmacol Ther. 2004. PMID: 15023164 Review.
Cited by
-
Risk of Rebleeding and Mortality in Cirrhotic Patients with Peptic Ulcer Bleeding: A 12-Year Nationwide Cohort Study.PLoS One. 2017 Jan 12;12(1):e0168918. doi: 10.1371/journal.pone.0168918. eCollection 2017. PLoS One. 2017. PMID: 28081567 Free PMC article. Clinical Trial.
-
Association of ABO Blood Type with Bleeding Severity in Patients with Acute Gastroesophageal Variceal Bleeding.Medicina (Kaunas). 2021 Dec 3;57(12):1323. doi: 10.3390/medicina57121323. Medicina (Kaunas). 2021. PMID: 34946268 Free PMC article.
-
Predicting risk factors for rebleeding, infections, mortality following peptic ulcer bleeding in patients with cirrhosis and the impact of antibiotics prophylaxis at different clinical stages of the disease.BMC Gastroenterol. 2015 May 20;15:61. doi: 10.1186/s12876-015-0289-z. BMC Gastroenterol. 2015. PMID: 26268474 Free PMC article.
-
The Dark Side of the Long-Term Use of Proton Pump Inhibitors in Chronic Liver Disease.GE Port J Gastroenterol. 2019 Mar;26(2):79-80. doi: 10.1159/000489640. Epub 2018 May 25. GE Port J Gastroenterol. 2019. PMID: 30976610 Free PMC article. No abstract available.
-
Bleeding complications in critically ill patients with liver cirrhosis.Korean J Intern Med. 2016 Mar;31(2):288-95. doi: 10.3904/kjim.2014.152. Epub 2016 Jan 25. Korean J Intern Med. 2016. PMID: 26805633 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical